PMID: 16524535Mar 10, 2006Paper

Carcinoid heart disease

Current Cardiology Reports
Heidi M Connolly, P A Pellikka

Abstract

Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome. Limited medical treatment options are available for patients with symptomatic carcinoid heart disease. At the Mayo Clinic (Rochester, MN), we have taken an aggressive approach to severe valvular dysfunction from carcinoid heart disease. Patients with severe carcinoid heart disease currently are referred for cardiac operation when they develop cardiac symptoms, ventricular dysfunction, or (rarely) in anticipation of hepatic surgery. Surgical outcome depends on patient age and functional class at the time of cardiac surgery. Despite metastatic disease that limits longevity, cardiac surgical survivors usually demonstrate dramatic improvement in functional capacity. Cardiac surgery should be considered early for patients with symptomatic carcinoid heart disease and controlled carcinoid symptoms. An experienced medical, surgical, and anesthetic team approach to the patient with carcinoid heart disease is critical in order to provide state of the art management.

References

Mar 1, 1976·Anaesthesia·R A Mason, P A Steane
Sep 11, 1986·The New England Journal of Medicine·L K KvolsR G Hahn
Oct 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C G Moertel
Aug 1, 1987·Annals of Internal Medicine·L K KvolsR G Hahn
Nov 1, 1985·Chest·V J DiSesaJ J Collins
Nov 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C G Moertel
Apr 1, 1983·The American Journal of Cardiology·C W ThorburnV P Chang
Jan 1, 1982·Chest·F R GutierrezC S Weldon
Jan 1, 1995·American Journal of Surgery·F G QueL K Kvols
Feb 1, 1995·Journal of the American College of Cardiology·H M ConnollyL K Kvols
Feb 15, 1997·Cancer·I M Modlin, A Sandor
Jul 15, 1997·The American Journal of Cardiology·W C Roberts
Jan 28, 1998·International Anesthesiology Clinics·D J Vaughan, M D Brunner
Sep 16, 1998·Lancet·M E CaplinA K Burroughs
Oct 13, 1998·Journal of the American College of Cardiology·W D DenneyB F Byrd
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J RubinL Anthony
Apr 10, 1999·The Annals of Thoracic Surgery·M L McDonaldH V Schaff
Feb 24, 2001·European Journal of Gastroenterology & Hepatology·P TomassettiL Gullo
Oct 18, 2002·Journal of the American College of Cardiology·Utpal H PandyaHeidi M Connolly
Mar 15, 2003·The New England Journal of Medicine·Jacob E MøllerPatricia A Pellikka
May 12, 2004·The American Journal of Cardiology·Nithima ChaowalitPatricia A Pellikka
Nov 16, 2005·Circulation·Jacob E MøllerHeidi M Connolly

❮ Previous
Next ❯

Citations

Jan 29, 2008·Current Treatment Options in Cardiovascular Medicine·Alain M BernheimPatricia A Pellikka
Aug 21, 2013·Current Treatment Options in Cardiovascular Medicine·J Wells Askew, Heidi M Connolly
Mar 19, 2014·International Journal of Cardiology·R DobsonD J Cuthbertson
Sep 4, 2010·Cardiovascular Ultrasound·Constantina AggeliChristodoulos Stefanadis
Jul 26, 2013·Endocrine-related Cancer·Rebecca DobsonMalcolm I Burgess
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catharina M KorseJohannes M G Bonfrer
Apr 27, 2011·Journal of cardiovascular ultrasound·Hong-Won ShinKwon-Bae Kim
Jun 28, 2019·Open Heart·Ali M AghaSaamir Hassan
Mar 11, 2020·Reviews in Endocrine & Metabolic Disorders·Giuseppe FanciulliUNKNOWN NIKE
Feb 6, 2009·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Deidi Ann Bergestuen, Svend Aakhus
Mar 1, 2014·Journal of the Saudi Heart Association·Afsoon FazlinezhadLeila Bigdelu
Apr 24, 2016·The Oncologist·Javier Molina-CerrilloEnrique Grande
Jun 22, 2017·Journal of Investigative Medicine High Impact Case Reports·Nicole BertinOlga Vriz
Jul 27, 2007·Nature Clinical Practice. Cardiovascular Medicine·Paru R ChaudhariEric Adler
Dec 26, 2006·Der Internist·P Rellecke, B E Strauer
Dec 9, 2017·Echo Research and Practice·Daniel HammersleyLydia Sturridge
Jan 15, 2021·European Heart Journal. Case Reports·Ali J EbrahimiMustafa Ahmed
Jun 15, 2021·European Heart Journal. Case Reports·Ronan O'DriscollMark Sader
Dec 11, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J BendelowG J Poston

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.